
ACIP no longer recommends routine use of PCV13 in immunocompetent adults ≥ 65 years. Three simple statements summarize guidance on intervals to follow when administering both PCV13 and PPSV23.
Aged, 80 and over, Male, Pneumococcal Vaccines, Immunocompromised Host, Vaccines, Conjugate, Practice Guidelines as Topic, Humans, Female, Family Practice, Immunization Schedule, Pneumococcal Infections, Aged
Aged, 80 and over, Male, Pneumococcal Vaccines, Immunocompromised Host, Vaccines, Conjugate, Practice Guidelines as Topic, Humans, Female, Family Practice, Immunization Schedule, Pneumococcal Infections, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
